EE03877B1 - Tropaan-2-aldoksiimi derivaadid neurotransmitteritagasihaarde inhibiitoritena - Google Patents

Tropaan-2-aldoksiimi derivaadid neurotransmitteritagasihaarde inhibiitoritena

Info

Publication number
EE03877B1
EE03877B1 EE9600132A EE9600132A EE03877B1 EE 03877 B1 EE03877 B1 EE 03877B1 EE 9600132 A EE9600132 A EE 9600132A EE 9600132 A EE9600132 A EE 9600132A EE 03877 B1 EE03877 B1 EE 03877B1
Authority
EE
Estonia
Prior art keywords
pct
reuptake inhibitors
tropane
date oct
neurotransmitter reuptake
Prior art date
Application number
EE9600132A
Other languages
English (en)
Estonian (et)
Other versions
EE9600132A (et
Inventor
Moldt Peter
W�tjen Frank
Scheel-Kr�ger J�rgen
Original Assignee
Neurosearch A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch A/S filed Critical Neurosearch A/S
Publication of EE9600132A publication Critical patent/EE9600132A/xx
Publication of EE03877B1 publication Critical patent/EE03877B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
EE9600132A 1994-04-19 1995-04-12 Tropaan-2-aldoksiimi derivaadid neurotransmitteritagasihaarde inhibiitoritena EE03877B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK44794 1994-04-19
DK133894 1994-11-24
PCT/EP1995/001358 WO1995028401A1 (en) 1994-04-19 1995-04-12 Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors

Publications (2)

Publication Number Publication Date
EE9600132A EE9600132A (et) 1997-04-15
EE03877B1 true EE03877B1 (et) 2002-10-15

Family

ID=26064021

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600132A EE03877B1 (et) 1994-04-19 1995-04-12 Tropaan-2-aldoksiimi derivaadid neurotransmitteritagasihaarde inhibiitoritena

Country Status (25)

Country Link
US (1) US5736556A (pl)
EP (1) EP0756596B1 (pl)
JP (1) JP2899418B2 (pl)
KR (1) KR100210417B1 (pl)
CN (1) CN1043763C (pl)
AT (1) ATE222587T1 (pl)
AU (1) AU690257B2 (pl)
BG (1) BG63259B1 (pl)
BR (1) BR9507489A (pl)
CA (1) CA2187309C (pl)
CZ (1) CZ284379B6 (pl)
DE (1) DE69527839T2 (pl)
DK (1) DK0756596T3 (pl)
EE (1) EE03877B1 (pl)
FI (1) FI965074A (pl)
GE (1) GEP19991749B (pl)
HU (1) HU215830B (pl)
LV (1) LV11738B (pl)
NO (1) NO964180L (pl)
NZ (1) NZ284075A (pl)
PL (1) PL183025B1 (pl)
RU (1) RU2134264C1 (pl)
SK (1) SK280875B6 (pl)
UA (1) UA49801C2 (pl)
WO (1) WO1995028401A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0859777T3 (da) * 1995-10-13 2007-09-03 Neurosearch As 8-azabicyclo[3.2.1]oct-2-en-derivater, deres fremstilling og anvendelse
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
HUP9802534A3 (en) * 1995-11-02 1999-06-28 Neurosearch As Fused tropane-derivatives as neurotransmitter reuptake inhibitors
US5948933A (en) * 1997-07-11 1999-09-07 Organix, Inc. Tropane analogs and methods for inhibition of monoamine transport
PT885220E (pt) * 1996-02-22 2001-11-30 Neurosearch As Derivados de tropano a sua preparacao e utilizacao
US6232326B1 (en) 1998-07-14 2001-05-15 Jodi A. Nelson Treatment for schizophrenia and other dopamine system dysfunctions
US6417177B1 (en) 1999-07-13 2002-07-09 Alpha Research Group, Llc Chloroquine derivatives for the treatment of Parkinson's disease
US20040229908A1 (en) * 1999-07-13 2004-11-18 Jodi Nelson Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
DK1526134T3 (da) * 2000-05-26 2008-11-17 Pfizer Triazolyltropanderivater som CCR5-modulatorer
US6667314B2 (en) 2000-05-26 2003-12-23 Pfizer, Inc. Tropane derivatives useful in therapy
EP1397358A1 (en) * 2001-05-23 2004-03-17 Neurosearch A/S Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US6610849B2 (en) * 2001-06-28 2003-08-26 Boehringer Ingelheim Pharma Kg Process for the manufacture of tropenol
ATE345135T1 (de) * 2001-11-30 2006-12-15 Neurosearch As Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
JP2005529156A (ja) * 2002-03-28 2005-09-29 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ トロパン化合物
AU2004278158B2 (en) 2003-10-03 2009-08-13 Pfizer Inc. Imidazopyridine substituted tropane derivatives with CCR5 receptor antagonist activity for the treatment of HIV and inflammation
EP2269608A3 (en) * 2003-10-16 2011-02-16 NeuroSearch AS Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
WO2005070427A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Compounds for the sustained reduction of body weight
WO2005070429A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
RU2352332C1 (ru) * 2005-01-14 2009-04-20 Частное Предприятие "Славянская Клиника" Применение местного анестетика для коррекции пищевого поведения человека и способ применения
EP1779851A1 (en) 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Treatment of diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds

Also Published As

Publication number Publication date
CA2187309A1 (en) 1995-10-26
CZ284379B6 (cs) 1998-11-11
RU2134264C1 (ru) 1999-08-10
CN1043763C (zh) 1999-06-23
EE9600132A (et) 1997-04-15
CZ298296A3 (en) 1997-06-11
HU9602707D0 (en) 1996-11-28
HU215830B (hu) 2001-05-28
CA2187309C (en) 2000-11-21
EP0756596A1 (en) 1997-02-05
LV11738A (lv) 1997-04-20
SK280875B6 (sk) 2000-08-14
LV11738B (en) 1997-12-20
JP2899418B2 (ja) 1999-06-02
ATE222587T1 (de) 2002-09-15
KR100210417B1 (ko) 1999-07-15
BG100883A (en) 1998-03-31
HUT75865A (en) 1997-05-28
FI965074A0 (fi) 1996-12-17
JPH09505607A (ja) 1997-06-03
AU2257595A (en) 1995-11-10
NO964180L (no) 1996-12-16
SK128896A3 (en) 1997-04-09
BG63259B1 (bg) 2001-07-31
WO1995028401A1 (en) 1995-10-26
CN1148854A (zh) 1997-04-30
GEP19991749B (en) 1999-09-10
DE69527839D1 (en) 2002-09-26
NZ284075A (en) 1998-01-26
BR9507489A (pt) 1997-08-12
NO964180D0 (no) 1996-10-02
FI965074A (fi) 1996-12-17
AU690257B2 (en) 1998-04-23
PL183025B1 (pl) 2002-05-31
PL316876A1 (en) 1997-02-17
US5736556A (en) 1998-04-07
UA49801C2 (uk) 2002-10-15
EP0756596B1 (en) 2002-08-21
MX9604966A (es) 1998-05-31
DK0756596T3 (da) 2002-12-23
DE69527839T2 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
FI965074A (fi) Tropaani-2-aldoksiinijohdannaisia hermoston välittäjäaineiden takaisinoton estäjinä
CA2244773A1 (en) Tropane-derivatives, their preparation and use
BR9610960A (pt) Derivados de 8-azabiciclo [3.2.1] oct -2- eno sua preparação e uso
IL110494A0 (en) Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
HRP20050213A2 (en) 2,4-substituted indoles and their use as 5-ht6 modulators
NO934761D0 (no) Antidepresjons- og antiparkinsonisme-forbindelser
NO934760L (no) Arylsubstituerte heterosykliske forbindelser
CA2112061A1 (en) Alkyl substituted heterocyclic compounds
BR9607841A (pt) Método para a preparação de estéres de anidroeggonina

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

MM4A Lapsed by not paying the annual fees

Effective date: 20030412